Hey Guys,
I came across this stock today and after doing an initial analysis, it really does look like a promising opportunity. I want to get a bit more of an understanding before coming to conclusion and was wondering if you have much material to understand the companies operations on a deeper level.
More specifically information in regards to their products, are they all purchased over the counter and does the customer need to get a prescription from a doctor or just need to ask for it?
In term's of operational leverage is there a specific reason it can get away with a 60% GP compared to other distributors and what are the arguments that this can be sustainable over the medium to long term?
- Forums
- ASX - By Stock
- BIO
- Ann: FY24 Revenue Guidance Upgrade to $12.5M
Ann: FY24 Revenue Guidance Upgrade to $12.5M, page-13
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
68.0¢ |
Change
0.015(2.26%) |
Mkt cap ! $149.0M |
Open | High | Low | Value | Volume |
66.5¢ | 69.0¢ | 66.0¢ | $173.2K | 255.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 46226 | 68.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
69.0¢ | 83602 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 44195 | 0.680 |
1 | 1000 | 0.670 |
8 | 41745 | 0.660 |
1 | 16550 | 0.655 |
5 | 27476 | 0.650 |
Price($) | Vol. | No. |
---|---|---|
0.690 | 48000 | 2 |
0.700 | 11170 | 2 |
0.705 | 5839 | 1 |
0.720 | 44230 | 3 |
0.735 | 18000 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
BIO (ASX) Chart |